Curavit Clinical Research Market Research Report
Company Overview
- Name: Curavit Clinical Research
- Mission: Revolutionizing clinical research through decentralized clinical trials (DCTs) to improve accessibility, engagement, and outcomes for patients and the industry.
- Founded by: Industry veterans Joel Morse and Dave Hanaman.
- Key People:
- Joel Morse: Chief Executive Officer. Founder and experienced CEO with a background in founding and building global businesses in healthcare and life sciences.
- Pam Diamond, MD: Chief Medical Officer. Board Certified Otolaryngologist/Head and Neck Surgeon with extensive affiliation with Harvard Medical School and Massachusetts Eye and Ear Infirmary.
- Dave Hanaman: President & Chief Commercial Officer. Proven entrepreneur with experience in successfully exiting strategic ventures.
- Jay Collier: Chief Operating Officer. Manages service delivery, having over 20 years of experience in life sciences and clinical research.
- Headquarters: No information is available.
- Number of Employees: No information is available.
- Revenue: No information is available.
- Known For: Specializes in decentralized clinical trials that replace traditional multi-site trials with virtual, central solutions designed to operate efficiently through telemedicine and digital tools.
Products and Services
Core Services
Curavit provides an extensive suite of Contract Research Organization (CRO) services specifically tailored for decentralized clinical trials:
1. Study Design: Collaborative design and planning for DCTs using modern approaches to ensure reliable trial processes.
2. IRB Review: Comprehensive management of Institutional Review Boards to confirm compliance with ethical standards and regulations.
3. Diverse Patient Recruitment: Innovative recruitment solutions targeting diverse and broad patient demographics without geographical limitations.
4. Consent & Enrollment: Streamlined process for remotely obtaining consent and enrolling participants.
5. Direct-to-Patient Logistics: Coordinating digital and physical logistics needed for decentralized trials.
6. Remote Patient Engagement: Utilizing technology to maintain patient interaction and engagement throughout the trial lifecycle.
7. Lab Coordination: Overseeing participants' external lab tests and procedures.
8. Clinical Oversight: Ensuring the quality and scientific integrity of trial operations.
9. Data Analytics: Employing advanced data management and analysis techniques for trial data.
10. Regulatory Compliance: Managing regulatory components to maintain compliance with all jurisdictional requirements.
Stratus: Curavit's DCT Platform
- A digital embodiment that facilitates decentralized clinical trials by leveraging modern technology such as wearable devices, telemedicine, and electronic patient-reported outcomes to collect diversified and vast datasets.
Recent Developments
New Partnerships and Trials
- Partnership with Swing Therapeutics: Collaborated to deploy a virtual site for a decentralized fibromyalgia study, enhancing patient enrollment and engagement.
- Collaboration with MedRhythms: Conducted auditory stimulation technology trials on stroke patients using a decentralized approach.
- Funding Accomplishments: Curavit successfully raised $5 million in Series A funding led by Osage Venture Partners to accelerate growth in digital therapeutics clinical research.
Industry Engagement
- DCT and HEOR Innovations: Curavit is pioneering methods in Health Economics and Outcomes Research (HEOR) to determine therapeutic value and surface unmet patient needs within its clinical trials.
- Publications and Thought Leadership: Actively contributing insights on digital therapeutics' role and potential in the healthcare industry, as well as promoting diversity and inclusion within clinical trials through various publications and forums.
Conclusion
Curavit Clinical Research is a trailblazer in the digital transformation of clinical trials. With an expert leadership team, innovative decentralized trial methodologies, and strategic partnerships, Curavit continues to advance the clinical research industry by improving trial design, patient engagement, and data collection through their virtual trial platforms.
(Note: For "key features of each product" and more detailed financial information, there's no available data.)
